364 related articles for article (PubMed ID: 27650916)
21. Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors.
Leite NC; Villela-Nogueira CA; Pannain VL; Bottino AC; Rezende GF; Cardoso CR; Salles GF
Liver Int; 2011 May; 31(5):700-6. PubMed ID: 21457442
[TBL] [Abstract][Full Text] [Related]
22. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD.
Hagström H; Nasr P; Ekstedt M; Hammar U; Stål P; Hultcrantz R; Kechagias S
J Hepatol; 2017 Dec; 67(6):1265-1273. PubMed ID: 28803953
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones.
García-Monzón C; Vargas-Castrillón J; Porrero JL; Alonso MT; Bonachía O; Castillo MJ; Marcos A; Quirós E; Ramos B; Sánchez-Cabezudo C; Villar S; Sáez A; Rodríguez de Cía J; del Pozo E; Vega-Piris L; Soto-Fernández S; Lo Iacono O; Miquilena-Colina ME
Liver Int; 2015 Aug; 35(8):1983-91. PubMed ID: 25708133
[TBL] [Abstract][Full Text] [Related]
24. The characteristics and risk factors of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis.
Tobari M; Hashimoto E; Taniai M; Kodama K; Kogiso T; Tokushige K; Yamamoto M; Takayoshi N; Satoshi K; Tatsuo A
J Gastroenterol Hepatol; 2020 May; 35(5):862-869. PubMed ID: 31597206
[TBL] [Abstract][Full Text] [Related]
25. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.
Angulo P; Kleiner DE; Dam-Larsen S; Adams LA; Bjornsson ES; Charatcharoenwitthaya P; Mills PR; Keach JC; Lafferty HD; Stahler A; Haflidadottir S; Bendtsen F
Gastroenterology; 2015 Aug; 149(2):389-97.e10. PubMed ID: 25935633
[TBL] [Abstract][Full Text] [Related]
26. SAF score and mortality in NAFLD after up to 41 years of follow-up.
Hagström H; Nasr P; Ekstedt M; Kechagias S; Stål P; Bedossa P; Hultcrantz R
Scand J Gastroenterol; 2017 Jan; 52(1):87-91. PubMed ID: 27616339
[TBL] [Abstract][Full Text] [Related]
27. Analytical, anthropometric and dietary factors associated with the development of fibrosis in patients with nonalcoholic fatty liver disease.
Gómez de la Cuesta S; Aller de la Fuente R; Tafur Sánchez C; Izaola O; García Sánchez C; Mora N; González Hernández JM; de Luis Román D
Rev Esp Enferm Dig; 2018 May; 110(5):292-298. PubMed ID: 29338271
[TBL] [Abstract][Full Text] [Related]
28. Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease.
McPherson S; Henderson E; Burt AD; Day CP; Anstee QM
J Hepatol; 2014 May; 60(5):1055-62. PubMed ID: 24445215
[TBL] [Abstract][Full Text] [Related]
29. Moderate alcohol consumption is not associated with subclinical cardiovascular damage but with hepatic fibrosis in non-alcoholic fatty liver disease.
Kashiwagi K; Yamaguchi A; Shiba S; Taniki N; Inoue N; Takaishi H; Iwao Y; Kanai T
Alcohol; 2020 Dec; 89():1-7. PubMed ID: 32738385
[TBL] [Abstract][Full Text] [Related]
30. Smoking is associated with severity of liver fibrosis but not with histological severity in nonalcoholic fatty liver disease. Results from a cross-sectional study.
Munsterman ID; Smits MM; Andriessen R; van Nieuwkerk CMJ; Bloemena E; Mulder CJJ; Tjwa ETTL; van Geenen EJM
Scand J Gastroenterol; 2017 Aug; 52(8):881-885. PubMed ID: 28446050
[TBL] [Abstract][Full Text] [Related]
31. Non-alcoholic fatty liver and advanced fibrosis in the elderly: Results from a community-based Polish survey.
Hartleb M; Barański K; Zejda J; Chudek J; Więcek A
Liver Int; 2017 Nov; 37(11):1706-1714. PubMed ID: 28489307
[TBL] [Abstract][Full Text] [Related]
32. Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis.
Ajmera V; Belt P; Wilson LA; Gill RM; Loomba R; Kleiner DE; Neuschwander-Tetri BA; Terrault N;
Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1511-1520.e5. PubMed ID: 29378307
[TBL] [Abstract][Full Text] [Related]
33. Nonheavy Drinking and Worsening of Noninvasive Fibrosis Markers in Nonalcoholic Fatty Liver Disease: A Cohort Study.
Chang Y; Cho YK; Kim Y; Sung E; Ahn J; Jung HS; Yun KE; Shin H; Ryu S
Hepatology; 2019 Jan; 69(1):64-75. PubMed ID: 30019340
[TBL] [Abstract][Full Text] [Related]
34. Alcohol consumption in patients with primary sclerosing cholangitis.
Hagström H; Stål P; Stokkeland K; Bergquist A
World J Gastroenterol; 2012 Jun; 18(24):3105-11. PubMed ID: 22791946
[TBL] [Abstract][Full Text] [Related]
35. A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients: multicentric study.
Abdel-Razik A; Mousa N; Shabana W; Refaey M; ElMahdy Y; Elhelaly R; Elzehery R; Zalata K; Arafa M; Elbaz S; Hafez M; Awad M
Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):e1-9. PubMed ID: 26469357
[TBL] [Abstract][Full Text] [Related]
36. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease.
Chen Y; Xu M; Wang T; Sun J; Sun W; Xu B; Huang X; Xu Y; Lu J; Li X; Wang W; Bi Y; Ning G
Atherosclerosis; 2015 Jul; 241(1):145-50. PubMed ID: 25988358
[TBL] [Abstract][Full Text] [Related]
37. Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD).
Johnston MP; Patel J; Byrne CD
Curr Pharm Des; 2020; 26(10):1079-1092. PubMed ID: 32003662
[TBL] [Abstract][Full Text] [Related]
38. Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD).
Dunn W; Sanyal AJ; Brunt EM; Unalp-Arida A; Donohue M; McCullough AJ; Schwimmer JB
J Hepatol; 2012 Aug; 57(2):384-91. PubMed ID: 22521357
[TBL] [Abstract][Full Text] [Related]
39. Coffee Intake and Liver Steatosis: A Population Study in a Mediterranean Area.
Veronese N; Notarnicola M; Cisternino AM; Reddavide R; Inguaggiato R; Guerra V; Rotolo O; Zinzi I; Leandro G; Correale M; Tutino V; Misciagna G; Osella AR; Bonfiglio C; Giannelli G; Caruso MG;
Nutrients; 2018 Jan; 10(1):. PubMed ID: 29342916
[TBL] [Abstract][Full Text] [Related]
40. Contrast-enhanced ultrasonography could be a non-invasive method for differentiating none or mild from severe fibrosis in patients with biopsy proven non-alcoholic fatty liver disease.
Nasr P; Hilliges A; Thorelius L; Kechagias S; Ekstedt M
Scand J Gastroenterol; 2016 Sep; 51(9):1126-32. PubMed ID: 27161854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]